Revolax Deep Lidocaine is a monophasic cross-linked hyaluronic acid dermal filler by REVOLAX, developed for deeper wrinkle correction, facial contouring and volume enhancement, with a thicker texture than REVOLAX Fine. It is suitable for aesthetic practitioners treating deep nasolabial folds and for facial augmentation, including the cheeks, chin and lips. The product contains 24 mg/mL of hyaluronic acid with 0.3% lidocaine (3 mg/mL) and is intended strictly for professional use.
主要优势: Revolax Deep Lidocaine
- Corrects deep nasolabial folds and supports facial contouring and augmentation
- Suitable for cheek, chin and lip augmentation, and for nose reshaping
- Thicker gel than REVOLAX Fine, for deeper placement
- Monophasic cross-linked hyaluronic acid at 24 mg/mL, cross-linked with BDDE
- Contains lidocaine hydrochloride 3 mg/mL, 0.3%, giving an analgesic effect during treatment
- Consistent extrusion force of 18.5 N, which supports controlled injection
- Supplied as a 1.1 ml syringe with two ultra thin wall 27G needles
- Duration of 8 to 12 months, with a 24 month shelf life
适应症与专业用途
主要适应症
- Intradermal implantation for volume loss and facial morphological asymmetry
- Deep nasolabial folds
- Face contouring and augmentation
- Cheek augmentation
- Chin augmentation
- Lip augmentation
- Forehead
- Nose augmentation (non-surgical rhinoplasty)
专业用途
Revolax Deep with Lidocaine is an injectable medical device for administration by trained medical professionals only, and is not for retail sale or self-administration. It is placed in the mid to deep dermis or the subcutaneous layer, depending on the treatment area and correction objective. Before treatment the patient's suitability and medical history must be assessed, and the patient informed of the indications, contraindications and possible adverse effects. The area to be treated should be disinfected thoroughly and the product injected under sterile conditions; keep the syringe at room temperature for 30 minutes before injection and press the plunger until a small drop is visible at the needle tip. It must not be injected into blood vessels, and it must not be injected into the eye contour, meaning the ocular circle or the eyelids. It must not be mixed with other products. If the needle blocks, do not increase pressure on the plunger rod; stop and replace the needle.
治疗部位
- Nasolabial folds and laugh lines
- Cheeks
- Chin
- Lips
- Forehead
- Nose
适用患者
For adult patients assessed as suitable by the treating practitioner, typically those presenting with deep nasolabial folds, facial contour deficits or volume loss in the cheeks, chin or lips. It must not be used in women who are pregnant or breastfeeding, in people under 18 years of age, in patients known to be hypersensitive to hyaluronic acid, or in patients who tend to develop hypertrophic scarring. It must not be used in association with laser therapy, chemical peeling or dermabrasion, or in areas presenting cutaneous inflammatory or infectious processes. It must not be used in patients with coagulation disorders, or who have received thrombolytic, anticoagulant or platelet aggregation inhibitor therapy in the previous two weeks. Because it contains lidocaine, the total dose administered must be taken into account where a dental block or topical lidocaine is used at the same time; high doses above 400 mg can cause acute toxic reactions affecting the central nervous system and cardiac conduction. Lidocaine should be used with caution in patients receiving other local anaesthetics or structurally related agents such as certain antiarrhythmics, and in patients with epilepsy, cardiac conduction disorders, severe hepatic impairment or severe renal dysfunction.
作用原理: Revolax Deep Lidocaine
Revolax Deep Lidocaine works through a monophasic, cross-linked hyaluronic acid gel at 24 mg/mL, combined with 0.3% lidocaine, placed in the mid to deep dermis or subcutaneous layer depending on the treatment area. This makes it suitable for correcting deep nasolabial folds and for facial contouring and augmentation of the cheeks, chin and lips.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVOLAX 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。
常见问题
Is Revolax Deep suitable for lips?
Yes. Lip contouring and augmentation are among the indications of Revolax Deep, alongside cheek and chin augmentation. Its thicker gel is intended for deeper placement than REVOLAX Fine, which is not positioned for volumising.
How does Revolax Deep differ from Revolax Fine and Revolax Sub-Q?
The three cover different depths. Revolax Fine is placed in the superficial dermis for superficial lines, with 30G needles. Revolax Deep goes into the mid to deep dermis or subcutaneous layer for deep nasolabial folds and facial contouring, with 27G needles. Revolax Sub-Q is the thickest gel, placed in the deep subcutaneous layer for severely deep lines and structural augmentation, with 25G needles.
How long does Revolax Deep last?
Revolax Deep lasts 8 to 12 months, and a clinical investigation confirmed safety and efficacy over a period of 48 weeks. The shelf life of an unopened syringe is 24 months.
更多产品: Across
诊所替代选择
继续浏览
Revolax Deep Lidocaine is a monophasic cross-linked hyaluronic acid dermal filler by REVOLAX, developed for deeper wrinkle correction, facial contouring and volume enhancement, with a thicker texture than REVOLAX Fine. It is suitable for aesthetic practitioners treating deep nasolabial folds and for facial augmentation, including the cheeks, chin and lips. The product contains 24 mg/mL of hyaluronic acid with 0.3% lidocaine (3 mg/mL) and is intended strictly for professional use.
主要优势: Revolax Deep Lidocaine
- Corrects deep nasolabial folds and supports facial contouring and augmentation
- Suitable for cheek, chin and lip augmentation, and for nose reshaping
- Thicker gel than REVOLAX Fine, for deeper placement
- Monophasic cross-linked hyaluronic acid at 24 mg/mL, cross-linked with BDDE
- Contains lidocaine hydrochloride 3 mg/mL, 0.3%, giving an analgesic effect during treatment
- Consistent extrusion force of 18.5 N, which supports controlled injection
- Supplied as a 1.1 ml syringe with two ultra thin wall 27G needles
- Duration of 8 to 12 months, with a 24 month shelf life
适应症与专业用途
主要适应症
- Intradermal implantation for volume loss and facial morphological asymmetry
- Deep nasolabial folds
- Face contouring and augmentation
- Cheek augmentation
- Chin augmentation
- Lip augmentation
- Forehead
- Nose augmentation (non-surgical rhinoplasty)
专业用途
Revolax Deep with Lidocaine is an injectable medical device for administration by trained medical professionals only, and is not for retail sale or self-administration. It is placed in the mid to deep dermis or the subcutaneous layer, depending on the treatment area and correction objective. Before treatment the patient's suitability and medical history must be assessed, and the patient informed of the indications, contraindications and possible adverse effects. The area to be treated should be disinfected thoroughly and the product injected under sterile conditions; keep the syringe at room temperature for 30 minutes before injection and press the plunger until a small drop is visible at the needle tip. It must not be injected into blood vessels, and it must not be injected into the eye contour, meaning the ocular circle or the eyelids. It must not be mixed with other products. If the needle blocks, do not increase pressure on the plunger rod; stop and replace the needle.
治疗部位
- Nasolabial folds and laugh lines
- Cheeks
- Chin
- Lips
- Forehead
- Nose
适用患者
For adult patients assessed as suitable by the treating practitioner, typically those presenting with deep nasolabial folds, facial contour deficits or volume loss in the cheeks, chin or lips. It must not be used in women who are pregnant or breastfeeding, in people under 18 years of age, in patients known to be hypersensitive to hyaluronic acid, or in patients who tend to develop hypertrophic scarring. It must not be used in association with laser therapy, chemical peeling or dermabrasion, or in areas presenting cutaneous inflammatory or infectious processes. It must not be used in patients with coagulation disorders, or who have received thrombolytic, anticoagulant or platelet aggregation inhibitor therapy in the previous two weeks. Because it contains lidocaine, the total dose administered must be taken into account where a dental block or topical lidocaine is used at the same time; high doses above 400 mg can cause acute toxic reactions affecting the central nervous system and cardiac conduction. Lidocaine should be used with caution in patients receiving other local anaesthetics or structurally related agents such as certain antiarrhythmics, and in patients with epilepsy, cardiac conduction disorders, severe hepatic impairment or severe renal dysfunction.
作用原理: Revolax Deep Lidocaine
Revolax Deep Lidocaine works through a monophasic, cross-linked hyaluronic acid gel at 24 mg/mL, combined with 0.3% lidocaine, placed in the mid to deep dermis or subcutaneous layer depending on the treatment area. This makes it suitable for correcting deep nasolabial folds and for facial contouring and augmentation of the cheeks, chin and lips.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVOLAX 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
Is Revolax Deep suitable for lips?
Yes. Lip contouring and augmentation are among the indications of Revolax Deep, alongside cheek and chin augmentation. Its thicker gel is intended for deeper placement than REVOLAX Fine, which is not positioned for volumising.
How does Revolax Deep differ from Revolax Fine and Revolax Sub-Q?
The three cover different depths. Revolax Fine is placed in the superficial dermis for superficial lines, with 30G needles. Revolax Deep goes into the mid to deep dermis or subcutaneous layer for deep nasolabial folds and facial contouring, with 27G needles. Revolax Sub-Q is the thickest gel, placed in the deep subcutaneous layer for severely deep lines and structural augmentation, with 25G needles.
How long does Revolax Deep last?
Revolax Deep lasts 8 to 12 months, and a clinical investigation confirmed safety and efficacy over a period of 48 weeks. The shelf life of an unopened syringe is 24 months.